An assessment of Parkinson's disease medication treatment patterns in the Medicaid population.

Johnsrud, Michael; Richards, Kristin; Arcona, Steve; Sasané, Rahul; Leoni, Matthew

Johnsrud, Michael; Richards, Kristin; Arcona, Steve; Sasané, Rahul; Leoni, Matthew.

Afiliación

Johnsrud M; TxCORE (Texas Center for Health Outcomes Research and Education), The University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA.
Richards K; TxCORE (Texas Center for Health Outcomes Research and Education), The University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA.
Arcona S; Cerevel Therapeutics, 222 Jacobs Street, Suite 200, Cambridge, MA 02141, USA.
Sasané R; Cerevel Therapeutics, 222 Jacobs Street, Suite 200, Cambridge, MA 02141, USA.
Leoni M; Cerevel Therapeutics, 222 Jacobs Street, Suite 200, Cambridge, MA 02141, USA.

Clin Park Relat Disord ; 5: 100109, 2021.

Article en En | MEDLINE | ID: mdl-34693271

Palabras clave

Dopamine agonist; Levodopa; Medicaid; Medication adherence; Parkinson's disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Park Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google